||**Mac Bevan Charitable Trust**|**Mac Bevan Charitable Trust**|**Mac Bevan Charitable Trust**|**No (if any)**|**No (if any)**|**No (if any)**|**CC16a**|
|---|---|---|---|---|---|---|---|
||**For the period**<br>**from**|01/01/2021|**To**||31/12/2021|||
|||||||||
|**Section A Receipts and payments**||||||||
|**A1 Receipts**|**Unrestricted**<br>**funds**<br>**to the nearest      £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**2,065**<br>**112,201**<br>**114,265**<br>**114,265**<br>**2,679**<br>**88,528**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br> **91,207**<br>**-**<br>**-**<br> **-**<br>**91,207**<br>**23,058**<br>**-**<br>**385,776**<br>**408,834**|**Restricted**<br>**funds**<br>**to the nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**Endowment**<br>**funds**<br>**to the nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**||**Total funds**<br>**to the nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**2,065**<br>**112,201**<br>**114,265**<br>**114,265**<br>**2,679**<br>**88,528**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**91,207**<br>**-**<br>**-**<br>**-**<br>**91,207**<br>**23,058**||**Last year**<br>**to the nearest £**|
|Donations & Gift Aid|**-**||||||**5,985**|
||**-**||||||**-**|
||**-**||||||**-**|
||**-**||||||**-**|
||**-**||||||**-**|
||**-**||||||**-**|
||**-**||||||**-**|
||**-**||||||**-**|
|**_Sub total_**_(Gross income for_<br>_AR)_|**-**||||||**5,985**|
|||||||||
|**A2 Asset and investment sales,**<br>**(see table).**||||||||
|Investment Income|**2,065**||||||**3,718**|
|Investment Gains|**112,201**||||||**106,691**|
|**_Sub total_**|**114,265**||||||**110,409**|
|**_Total receipts_**<br>**A3 Payments**||||||||
||||||||**116,394**|
|||||||||
|Costs of fundraising|**2,679**||||||**18,249**|
|Costs of charitable activities|**88,528**||||||**105,478**|
||**-**||||||**-**|
||**-**||||||**-**|
||**-**||||||**-**|
||**-**||||||**-**|
||**-**||||||**-**|
||**-**||||||**-**|
||**-**||||||**-**|
|**_Sub total_ **|**91,207**||||||**123,727**|
|||||||||
|**A4 Asset and investment**<br>**purchases, (see table)**||||||||
||**-**|||||||
||**-**|||||||
|**_Sub total_ **|**-**||||||**-**|
|**_Total payments_**<br>**_Net of receipts/(payments)_**<br>**A5 Transfers between funds**<br>**A6 Cash funds last year end**<br>**_Cash funds this year end_**||||||||
||||||||**123,727**|
|||||||||
||**23,058**|**-**|**-**||**23,058**||**-                 7,333**|
||**-**|**-**|**-**||**-**||**-**|
||**385,776**|**-**|**-**||**385,776**||**385,776**|
||**408,834**|**-**|**-**||**408,834**||**-**|



14/10/2022 

CCXX R1 accounts (SS) 

1 



|**Section B Statement of assets and liabilities at the end of the**|**Section B Statement of assets and liabilities at the end of the**|**Section B Statement of assets and liabilities at the end of the**|**period**||
|---|---|---|---|---|
|**Categories**<br>**B5 Liabilities**<br>**B4 Assets retained for the**<br>**charity’s own use**<br>**B3 Investment assets**<br>**B2 Other monetary assets**<br>**B1 Cash funds**|UBP<br>SYZ<br>**Details**<br>**Details**<br>Computer & Server<br>**Details**<br>**Details**<br>Barclays<br>HSBC<br>**_Total cash funds_**<br>(agree balances with receipts and payments<br>account(s))<br>**Details**|**Unrestricted**<br>**funds**<br>**to nearest £**<br>**41,650**<br>**231,254**<br>**32,004**<br>**103,925**<br>**408,834**<br>OK<br>**Unrestricted**<br>**funds**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**asset belongs**<br>**Fund to which**<br>**asset belongs**<br>Unrestricted<br>**Fund to which**<br>**liability relates**|**Restricted**<br>**funds**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>OK<br>**Restricted**<br>**funds**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Cost (optional)**<br>**2,300**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Amount due**<br>**(optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**Endowment**<br>**funds**<br>**to nearest £**|
|||||**-**|
|||||**-**|
||||||
||||||
||||||
|||||**-**|
||||||
|||||**-**|
|||||OK|
|||||**Endowment**<br>**funds**<br>**to nearest £**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**Current value**<br>**(optional)**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**Current value**<br>**(optional)**|
|||||**2,300**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**When due**<br>**(optional)**|
||||**-**||
||||**-**||
||||**-**||
||||**-**||
||||**-**||



14/10/2022 

CCXX R2 accounts (SS) 

2 



Signed by one or two trustees on behalf of all the trustees 

Date of Signature Print Name approval 

14/10/2022 

CCXX R3 accounts (SS) 

3 

